Artwork

Sisällön tarjoaa The Radcliffe Cardiology Podcast. The Radcliffe Cardiology Podcast tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

12:40
 
Jaa
 

Manage episode 318823677 series 2990303
Sisällön tarjoaa The Radcliffe Cardiology Podcast. The Radcliffe Cardiology Podcast tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Did you know that left main stem disease is identified in 5% of diagnostic angiography cases? The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a deterioration in the relationship between the cardiothoracic and PCI communities. In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper: https://www.ecrjournal.com/articles/excel-trial-interventionalists-perspective?_ga=2.187238699.2063070761.1642409370-1520007507.1640163023 from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today. If you would like to learn more about the EXCEL Trial, view our special collection here: https://www.ecrjournal.com/special-collections/445/recent Episodes are released on the last Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com.
  continue reading

43 jaksoa

Artwork
iconJaa
 
Manage episode 318823677 series 2990303
Sisällön tarjoaa The Radcliffe Cardiology Podcast. The Radcliffe Cardiology Podcast tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Did you know that left main stem disease is identified in 5% of diagnostic angiography cases? The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a deterioration in the relationship between the cardiothoracic and PCI communities. In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper: https://www.ecrjournal.com/articles/excel-trial-interventionalists-perspective?_ga=2.187238699.2063070761.1642409370-1520007507.1640163023 from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today. If you would like to learn more about the EXCEL Trial, view our special collection here: https://www.ecrjournal.com/special-collections/445/recent Episodes are released on the last Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com.
  continue reading

43 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas